Present Status and Perspectives in the Treatment of Hormone-Refractory Prostate Cancer

Publisher： Karger

E-ISSN： 1423-0232|69|4|273-282

ISSN： 0030-2414

Source： Oncology, Vol.69, Iss.4, 2005-12, pp. : 273-282

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

TREATMENT WITH PREDNISOLONE OF HORMONE-REFRACTORY PROSTATE CANCER

By Fuse H.   Nozaki T.   Fujiuchi Y.   Mizuno I.   Nagakawa O.   Okumura A.  

Archives of Andrology, Vol. 52, Iss. 1, 2006-01 ,pp. : 35-38

Informa Healthcare

Access to resources Recommend Favorite

Role of Chemotherapy in Hormone-Refractory Prostate Cancer

By  

Urologia Internationalis, Vol. 70, Iss. 1, 2003-02 ,pp. : 1-14

Karger

Access to resources Recommend Favorite

Prednisone plus Gefitinib versus Prednisone plus Placebo in the Treatment of Hormone-Refractory Prostate Cancer: A Randomized Phase II Trial

By  

Oncology, Vol. 74, Iss. 3-4, 2008-08 ,pp. : 223-228

Karger

Access to resources Recommend Favorite

Prospective Evaluation of Samarium-153-EDTMP Radionuclide Treatment for Bone Metastases in Patients with Hormone-Refractory Prostate Cancer

By  

Urologia Internationalis, Vol. 78, Iss. 1, 2007-01 ,pp. : 50-57

Karger

Access to resources Recommend Favorite

REDISTRIBUTION OF ANDROGEN RECEPTORS IN ACQUIRED HORMONE-REFRACTORY PROSTATE CANCER CELLS

By Yu D. S.   Hsieh D. S.   Chang S. Y.  

Archives of Andrology, Vol. 52, Iss. 5, 2006-09 ,pp. : 389-395

Informa Healthcare

Access to resources Recommend Favorite